Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Friday's Pre-Market Session

Author: Benzinga Insights | April 21, 2023 09:06am

Gainers

  • NovaBay Pharmaceuticals (AMEX:NBY) shares moved upwards by 25.3% to $1.93 during Friday's pre-market session. The company's market cap stands at $3.9 million.
  • Onconova Therapeutics (NASDAQ:ONTX) stock increased by 22.52% to $0.86. The market value of their outstanding shares is at $18.0 million.
  • Aziyo Biologics (NASDAQ:AZYO) stock increased by 21.68% to $2.02. The company's market cap stands at $32.7 million.
  • Cyclo Therapeutics (NASDAQ:CYTH) shares moved upwards by 14.52% to $0.81. The market value of their outstanding shares is at $8.5 million.
  • CytoMed Therapeutics (NASDAQ:GDTC) stock increased by 12.61% to $3.75. The company's market cap stands at $41.0 million.
  • Compass Therapeutics (NASDAQ:CMPX) shares rose 11.51% to $3.1. The market value of their outstanding shares is at $392.1 million.

Losers

  • Candel Therapeutics (NASDAQ:CADL) shares decreased by 14.9% to $1.2 during Friday's pre-market session. The market value of their outstanding shares is at $34.7 million.
  • Vallon Pharmaceuticals (NASDAQ:VLON) stock decreased by 13.05% to $0.4. The company's market cap stands at $5.3 million.
  • Aditxt (NASDAQ:ADTX) shares decreased by 12.43% to $0.88. The company's market cap stands at $3.7 million.
  • Plus Therapeutics (NASDAQ:PSTV) shares fell 12.0% to $0.27. The market value of their outstanding shares is at $9.5 million. As per the press release, Q1 earnings came out yesterday.
  • Sonnet BioTherapeutics (NASDAQ:SONN) stock decreased by 11.26% to $0.27. The market value of their outstanding shares is at $5.4 million.
  • Vincerx Pharma (NASDAQ:VINC) stock fell 9.1% to $0.91. The company's market cap stands at $19.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ADTX AZYO CADL CMPX CYTH GDTC NBY ONTX PSTV SONN VINC VLON

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist